Correction to: Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer
- PDF / 213,292 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 4 Downloads / 241 Views
CORRECTION
Correction to: Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer Fernanda Bueno1 María Gabriela García Falcone1 Mirna Angela Peñaloza1 Erika Abelleira1 Fabián Pitoia1 ●
●
●
●
© Springer Science+Business Media, LLC, part of Springer Nature 2020
1234567890();,:
1234567890();,:
Correction to: Endocrine https://doi.org/10.1007/s12020-019-02112-7
The original article can be found online at https://doi.org/10.1007/ s12020-019-02112-7. * Fabián Pitoia [email protected] 1
Division of Endocrinology, Hospital de Clínicas-University of Buenos Aires, Buenos Aires, Argentina
The original version of this article unfortunately contained a mistake in Table 3. The initial levels of Tg Ab was incorrectly transcribed. The corrected Table 3 is given below.
Endocrine Table 3 Baseline characteristics and comparison of the responses to therapy in patients with detectable TgAb with and without radioiodine remnant ablation Radioiodine remnant ablation (RA) Without RA (n = 23) Sex (n, %) Female 18 (78.3) Male 5 (21.7) Age (years) Median (range) 42 (27–69) Histology (n, %) Papillary 22 (95.7) Follicular 1 (4.3) Lymphocytic thyroiditis (n, %) 17 (73.9) Initial TgAb median IU/ml (range) 194 (0–2000) TgAb trend at 12 months (n, %) Undetectable 5 (21.7) Decreased 14 (60.9) Stable 1 (4.3) Increased 3 (13) Unknown 0 Initial response to treatment (n, %) Excellent response 8 (34.8) Indeterminate response 15 (65.2) Biochemical incomplete 0 Structural incomplete 0 Clinical status at 36 months of follow up NED (n, %) 8 (34.8) Indeterminate (n, %) 15 (65.2) Biochemical incomplete (n, %) 0 Structural incomplete (n, %) 0 Time to undetectable TgAb (months) Median (range) 11.25 (6–21) Time of follow-up (months) Median (range) 27 (16–42)
With RA (n = 30)
p
27 (90) 3 (10)
0.237a
44 (29–76)
0.2697b
30 (100) 0 14 (46.7) 98 (0–1180)
0.249a 0.741a 0.1435b
1 15 6 2 6
(3.3) (50) (20) (6.7) (20)
0.006a
7 21 1 1
(23.4) (70) (3.3) (3.3)
0.610a
9 (30) 19 (63.3) 0 2 (6.7)
0.442a
16 (11–36)
0.0232b
82 (27–210)
RA radioiodine remnant ablation, TgAb anti-thyroglobulin antibodies, NED no evidence of disease a
p values were determined by the χ2 test p values were determined by the Mann–Whitney U test
b
Data Loading...
